about
Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data reviewPhenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-clonic seizuresPhenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizuresCarbamazepine versus phenobarbitone monotherapy for epilepsyPiracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placeboCognitive function--victim of disease or hostage to treatment?Carbamazepine versus phenytoin monotherapy for epilepsy.History of neuropsychology through epilepsy eyes.Prophylaxis and treatment of posttraumatic epilepsy with phenytoin.Phenobarbital for the treatment of epilepsy in the 21st century: a critical review.Rapid tolerance to acute psychomotor impairment with carbamazepine in epileptic patients.Childhood epilepsy in relation to mental handicap and behavioural disorders.Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.Efficacy and adverse effects of established and new antiepileptic drugs.Newer antiepileptic drugs and cognitive issues.Determining the effects of antiepileptic drugs on cognitive function in pediatric patients with epilepsy.Neuropsychological and behavioral effects of antiepilepsy drugs.CNS adverse events associated with antiepileptic drugs.Behavioral impairments in rats with chronic epilepsy suggest comorbidity between epilepsy and attention deficit/hyperactivity disorderAdverse cognitive effects of phenytoin in severe brain injury: a case report.The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy.Attention-deficit/hyperactivity disorder symptoms in adults with self-reported epilepsy: Results from a national epidemiologic survey of epilepsy.Standard approach to antiepileptic drug treatment in the United States.Advances in the assessment of refractory epilepsy.Clinical uses of the quality-of-life in epilepsy inventory.Epilepsy in older adults: causes, consequences and treatment.Cognitive and behavioral effects of antiepileptic drugs.Cognitive functions, epileptic syndromes and antiepileptic drugs.The role of the old and the new antiepileptic drugs in special populations: mental and multiple handicaps.Effects of antiepileptic drugs on cognition.Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers.Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures.Vagus Nerve Stimulation As Treatment for Epileptic Seizures.
P2860
Q24186327-438DCBB7-BC2E-4B35-8D19-F4307E0A90BDQ24201696-50F8F1DB-81F1-4D1F-8041-8E57A1F5C481Q24248718-0258553B-F482-46A6-84AD-85244AEA1C12Q24250193-5443303F-A818-48F1-8B0F-A26776D742E1Q24680177-B62DC4EC-AF96-4BD2-8200-37CE899FA9F0Q30439343-3EDF4AA9-714C-4FA5-994F-EBB712C94813Q31083753-9381C843-B4BA-4F99-8E68-07536DCFBAB6Q33860527-B27B8292-1FFA-4ADB-B9D9-DA77B139AD8FQ34294527-FD24F462-C63A-432A-BAD3-9CBFD9ACD664Q34343308-65ED69C8-D59E-4F8B-B649-0103270DB301Q34402587-3F43670E-CE74-4150-A11E-EB34F6DEB858Q34540188-D0DBF5DD-DBDA-4DC9-A93C-3FFD6CDB0545Q34547394-E17A751F-3DC1-402A-B359-7DDFF1C589D4Q34734496-3EC7B929-A3D5-431A-8CB8-7E2E4C5425C5Q35161333-DA8BAAC8-7125-4ACC-BA80-F0CE6727AE74Q35939585-1801560E-F49D-4B5F-B5A7-160892C60FFCQ36974353-CB226EFE-CC0E-4B82-8449-990C93B158F1Q37242600-4BEC0953-C847-4199-8A04-5E8B7E011FDDQ37624913-F464ED75-7C40-4562-A259-408F16E52DBBQ37870925-8D295439-3A18-48B6-95A5-91E379643461Q38505575-BF7D461B-3943-41D7-98A2-31735543824BQ39056793-AA10FC21-BA10-4063-B1E4-33718986BA22Q40748908-B841327B-F5B8-4941-AAF6-C898C1BF322EQ40829514-32BD2896-136C-45D6-B405-017BE3824BC8Q40833720-EA048AD9-075F-4C87-8278-7F6470CC9EB4Q40839396-728560A8-ED22-48B3-BBC4-E10566F0CC0EQ41000788-092C0688-310B-4E52-A47F-E104EBF352B8Q41123314-3FC07C66-8ECE-45B1-93ED-B3B3F11CB081Q41240640-49DB227A-49B8-4CF7-A65A-507228588535Q43650825-397546C1-B740-401F-9ECD-313D2A6F9D0EQ44004463-6BF036E9-8F9F-4756-96C5-49B06D9986FDQ48240944-1D1D0DE6-2504-4012-B40D-7E4412B28F1CQ48633829-CF79FCEB-C6CA-4B90-AAE4-333E8236B0D2
P2860
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Comparative cognitive effects of anticonvulsants.
@en
Comparative cognitive effects of anticonvulsants.
@nl
type
label
Comparative cognitive effects of anticonvulsants.
@en
Comparative cognitive effects of anticonvulsants.
@nl
prefLabel
Comparative cognitive effects of anticonvulsants.
@en
Comparative cognitive effects of anticonvulsants.
@nl
P2093
P1433
P1476
Comparative cognitive effects of anticonvulsants.
@en
P2093
P304
P356
10.1212/WNL.40.3_PART_1.391
P407
P433
P577
1990-03-01T00:00:00Z